Thalidomide to treat multiple myeloma

 

Few drugs, if any, have achieved the sad notoriety of thalidomide. Introduced in the late 1950s, it caused congenital birth defects in thousands of children worldwide and has been one of the most cautionary tales in the history of medicine. The medicine was banned at the beginning of the 1960s. During the years that followed, some beneficial effects of thalidomide were recognised for various disorders, and in Europe, since the ban, thalidomide has been used off-license and prescribed on a compassionate basis, mainly in hospitals.
 
In 2002, the European Medicines Agency (EMEA) received four marketing authorisation applications for thalidomide, which brought issues back to the surface. For the thalidomide victim associations, it was simply unacceptable that the drug be licensed again, and for the patient associations, it represented a major medical progress against their ailment.
 
As of 2006, however, no marketing applications had been authorised. Eurordis continued to work with all stakeholders to encourage marketing authorisation for thalidomide under strong safety guidelines.
 
For more information: Eurordis’ newsletter article - November 2006

 

 
 
La voce dei malati rari in EuropaEURORDIS Rare Diseases International, la voce internazionale dei malati rariRare Disease International RareConnect è un'iniziativa di EURORDIS che mette in contatto malati, famiglie ed esperti per condividere esperienze in un forum multilingua e moderato RareConnect Il Programma Rare Barometer è un’iniziativa di EURORDIS volta a condurre indagini con l’obiettivo di trasformare le esperienze delle persone affette da malattie rare in cifre e fatti che possono essere condivisi con i decisori politici.Rare Barometer La Giornata delle Malattie Rare, una campagna di sensibilizzazione internazionale che si svolge l'ultimo giorno di febbraio di ogni anno.Rare Disease Day La Conferenza Europea biennale sulle Malattie Rare è il più grande incontro di soggetti interessati al tema delle Malattie Rare in Europa. L'ECRD è un'iniziativa di EURORDISEuropean Conference on Rare Diseases